NCT06052137View on ClinicalTrials.gov

Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression

NAActive, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Treatment Resistant Depression
Interventions
DEVICE

Active TBS-DLPFC

"Participants will receive intermittent TBS to left DLPFC. The L-DLPFC will be targeted utilizing the Localite neuronavigation system. Stimulation intensity will be standardized at 90% of RMT and adjusted to the skull to cortical surface distance (see Nahas 2004).~Stimulation will be delivered to the L-DLPFC using a MagPro TMS system (MagVenture, Denmark)."

DEVICE

TBS-DMPFC

"Participants will receive intermittent TBS to DMPFC. The DMPFC will be targeted utilizing the Localite neuronavigation system. Stimulation intensity will be standardized at 90% of RMT and adjusted to the skull to cortical surface distance (see Nahas 2004).~Stimulation will be delivered to the DMPFC using a MagPro TMS system (MagVenture, Denmark)."

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT06052137 - Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression | Biotech Hunter | Biotech Hunter